MedTrace Logo

The Effect of Melatonin Administration on Sedation Level as Adjuvant to Propofol

NCT04034771 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2019-07-26

No results posted yet for this study

Summary

This study assess the effect of administration of exogenous melatonin as adjuvant to propofol on the level of sedation and consequently the rate of propofol infusion.

Conditions

  • TBI (Traumatic Brain Injury)

Interventions

DRUG

Melatonin 10 MG Oral Tablet

Melatonin tablets

DRUG

Propofol

propofol amp

DRUG

Placebo oral tablet

sugar pill manufactured to mimic melatonin tablets

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mahmoud s Soliman, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-04-01
Completion
2018-04-05

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04034771 on ClinicalTrials.gov